Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469755

COc1cc2c(C)nc(Nc3nc(O)c4c(OC)cccc4n3)nc2cc1F.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MAPT P10636 6/20 0.38
TP53 P04637 5/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 3/20 0.37
RAD52 P43351 2/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ABCG2 Q9UNQ0 1/20 0.37
WHR1 P49842 2/20 0.36
NPC1 O15118 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
EHMT2 Q96KQ7 1/20 0.35
ELANE P08246 1/20 0.35
RAF1 P04049 1/20 0.34
BRAF P15056 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6470334 0.93 ABCG2 (0.42) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467878 0.90 KMT2A (0.47) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6466274 0.88 KMT2A (0.39) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6470578 0.88 TDP2 (0.46) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467192 0.86 WHR1 (0.41) KMT2AMAPTTP53POLBSMN1; SMN2
SCHEMBL6469759 0.84 KMT2A (0.37) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467073 0.84 KMT2A (0.39) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467330 0.84 ABCG2 (0.39) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467857 0.83 AURKA (0.40) KMT2AMAPTTP53POLBSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6469497 0.82 WHR1 (0.40) KMT2AMAPTTP53POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KMT2A 2156/4885MAPT 3552/4885TP53 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.